Related Experiment Video
Updated: Feb 12, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Restorative effect of l-Dopa treatment against Ochratoxin A induced neurotoxicity
Pratiksha V Bhat1, T Anand1, T Mohan Manu1
1Nutrition, Biochemistry and Toxicology Division, Defence Food Research Laboratory, Siddarthanagar, Mysore, 570011, India.
Abstract:
The toxic effects of Ochratoxin A (OTA), a fungal secondary metabolite of the genera Aspergillus and Penicillium with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) a Parkinson inducing drug were investigated to evaluate the neurotoxic effects exerted by OTA. OTA is known to contaminate food and feedstuff leading to a wide range of toxicity like nephrotoxicity, hepatotoxicity, and immunotoxicity. However, due to the dearth of available information on the possible mechanisms of OTA neurotoxicity and neurodegeneration the current study was undertaken. Hence, in this study, we examined the neurotoxic effects and the possible mechanism of action of neurodegeneration by OTA toxicity on mice brain by conducting a battery of behavioural studies and reviewing neurotransmitter levels and neuronal apoptotic pathways. Further, they were treated with l-Dopa, a precursor of dopamine (DA) to explore its ameliorative effects against OTA. The results of behavioural studies like gait analysis, spontaneous activity, cylinder test and pole test showed that OTA exhibits Parkinsonian physiognomies which were stabilized with l-Dopa treatment. Also, OTA toxicity showed insults on neurotransmitter levels and general brain function parameters that were normalized with l-Dopa treatment. The results of the present study suggest that OTA promotes neurodegeneration by targeting neuronal pathway leading to the development of Parkinson's diseases.
Insights
Ochratoxin A (OTA) exposure in mice induced Parkinson
Area of Science:
- Neuroscience
- Toxicology
- Mycotoxicology
Background:
- Ochratoxin A (OTA) is a fungal toxin contaminating food and feed.
- OTA causes nephrotoxicity, hepatotoxicity, and immunotoxicity.
- Mechanisms of OTA-induced neurotoxicity and neurodegeneration are poorly understood.
Purpose of the Study:
- To investigate the neurotoxic effects of Ochratoxin A (OTA).
- To elucidate the mechanism of OTA-induced neurodegeneration.
- To evaluate the therapeutic potential of l-Dopa against OTA neurotoxicity.
Main Methods:
- Behavioral studies (gait analysis, spontaneous activity, cylinder test, pole test) in mice.
- Assessment of neurotransmitter levels and neuronal apoptotic pathways.
- Administration of l-Dopa to explore ameliorative effects.
Main Results:
- OTA exposure induced Parkinsonian symptoms in mice.
- OTA toxicity negatively impacted neurotransmitter levels and brain function.
- l-Dopa treatment stabilized Parkinsonian symptoms and normalized brain function parameters.
Conclusions:
- Ochratoxin A (OTA) promotes neurodegeneration.
- OTA targets neuronal pathways implicated in Parkinson's disease development.
- l-Dopa shows potential in ameliorating OTA-induced neurotoxicity.
More Related Videos
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
06:38Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
Published on: June 11, 2017
Related Concept Videos
Restorative Care
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...